Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-179907
Filing Date
2014-05-02
Accepted
2014-05-02 14:55:58
Documents
11
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q d706022d10q.htm 10-Q 368093
2 EX-31.1 d706022dex311.htm EX-31.1 5707
3 EX-31.2 d706022dex312.htm EX-31.2 5993
4 EX-32.1 d706022dex321.htm EX-32.1 3164
5 EX-32.2 d706022dex322.htm EX-32.2 3463
  Complete submission text file 0001193125-14-179907.txt   3700701

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT cbrx-20140331.xml EX-101.INS 432463
7 XBRL TAXONOMY EXTENSION SCHEMA cbrx-20140331.xsd EX-101.SCH 46262
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE cbrx-20140331_cal.xml EX-101.CAL 74602
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE cbrx-20140331_def.xml EX-101.DEF 126009
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE cbrx-20140331_lab.xml EX-101.LAB 338794
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE cbrx-20140331_pre.xml EX-101.PRE 234828
Mailing Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109
Business Address 4 LIBERTY SQUARE 4TH FLOOR BOSTON MA 02109 973-486-8820
COLUMBIA LABORATORIES INC (Filer) CIK: 0000821995 (see all company filings)

EIN.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-10352 | Film No.: 14808943
SIC: 2834 Pharmaceutical Preparations